Citation Impact
Citing Papers
Management of the social impacts of mining
2011
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
2012
Prostate cancer in Asian men
2014
Prospective assessment of the efficacy of single dose versus traditional 3‐day antimicrobial prophylaxis in 12‐core transrectal prostate biopsy
2008
Actinomyces meyeri infection: Case report and review of the literature
2012
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
2014 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Actinomyces and Related Organisms in Human Infections
2015 Standout
Cancer statistics in China, 2015
2016 Standout
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group
2015
Social impact assessment: the state of the art
2012 Standout
Works of Weranja Ranasinghe being referenced
Subphrenic Abscess Secondary to Actinomycosis meyeri and Klebsiella ozaenae Following Laparoscopic Cholecystectomy
2009
Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups
2018
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England
2011
ANTIBIOTICS FOR TRANSRECTAL ULTRASONOGRAPHY‐GUIDED PROSTATE BIOPSY: ARE WE PRACTISING EVIDENCE‐BASED MEDICINE?
2008
Population‐based analysis of prostate‐specific antigen ( PSA ) screening in younger men (<55 years) in A ustralia
2013